Attri Dharam Chand, Dhyani Praveen, Trivedi Vijay Laxmi, Sharma Eshita, Ibrayeva Manshuk, Jantwal Arvind, Sati Priyanka, Calina Daniela, Sharifi-Rad Javad
Department of Botany, Central University of Jammu, Rahya-Suchani (Bagla)-181143, Jammu and Kashmir, India.
University of Koblenz, Institute for Integrated Natural Sciences, Koblenz Germany.
Curr Med Chem. 2024 Jun 11. doi: 10.2174/0109298673295496240530100728.
Cancer, a diverse group of diseases characterized by abnormal cell growth and the potential to spread throughout the body, accounts for approximately 10 million deaths globally each year. Current cancer therapies, including chemotherapy, radiation, and various pharmacological treatments, present several challenges and potential side effects. It is important to differentiate these conventional methods, which often involve synthetic drugs, from adjuvant therapies that might be used in conjunction. As a result, there is an increasing interest in alternative therapies, particularly in agents derived from natural sources for cancer treatment. Secondary metabolites have shown promise in promoting the development of new clinical drugs with various anti-cancer mechanisms. This review focuses on the anti-cancer potential of the novel metabolite Andrographolide, extracted mainly from Andrographis paniculata. The chemopreventive properties and the ability to inhibit various signaling pathways across different types of cancers without side effects posit Andrographolide as a promising natural antitumour agent. The review identified that Andrographolide inhibits multiple signaling pathways, contributing to its anti-proliferative, anti-metastatic, and apoptotic effects in various cancers. The compound's natural origin and lack of adverse side effects make it particularly attractive as a therapeutic agent. However, further detailed studies are needed to fully understand its specific mechanisms and potential clinical applications. Andrographolide presents a compelling option as a natural anticancer agent with the potential to overcome some limitations of traditional cancer treatments. Its broad spectrum of anti-cancer activities and absence of side effects highlight its therapeutic potential. The review highlights that continued research and clinical studies are important for confirming the effectiveness and safety of Andrographolide in human use, alongside optimizing dosage and delivery techniques.
癌症是一组多样的疾病,其特征为细胞异常生长并有可能扩散至全身,全球每年约有1000万人死于癌症。当前的癌症治疗方法,包括化疗、放疗和各种药物治疗,都存在一些挑战和潜在的副作用。区分这些通常涉及合成药物的传统方法与可能联合使用的辅助疗法很重要。因此,人们对替代疗法的兴趣与日俱增,尤其是对源自天然来源的癌症治疗药物。次生代谢产物在促进具有各种抗癌机制的新型临床药物的开发方面已显示出前景。本综述重点关注主要从穿心莲中提取的新型代谢产物穿心莲内酯的抗癌潜力。穿心莲内酯的化学预防特性以及在不同类型癌症中抑制各种信号通路而无副作用的能力,使其成为一种有前景的天然抗肿瘤药物。该综述发现,穿心莲内酯抑制多种信号通路,从而在各种癌症中发挥抗增殖、抗转移和凋亡作用。该化合物的天然来源和无不良副作用使其作为治疗剂特别具有吸引力。然而,需要进一步详细研究以充分了解其具体机制和潜在的临床应用。穿心莲内酯作为一种天然抗癌剂,有可能克服传统癌症治疗的一些局限性,是一个引人注目的选择。其广泛的抗癌活性和无副作用突出了其治疗潜力。该综述强调,持续的研究和临床研究对于确认穿心莲内酯在人类使用中的有效性和安全性,以及优化剂量和给药技术很重要。